Infectious Diseases

Sandy Capaldi of the Perelman School of Medicine defines agoraphobia and explains what distinguishes it from other anxiety disorders in the context of the pandemic.

Jeffrey S. Morris of the Perelman School of Medicine says that people have become apathetic about COVID-19 but that long COVID’s loose symptoms make determining its risk difficult.

Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for their key 2005 advances with synthetic mRNA.

Capstan Therapeutics, a Penn spinout whose founders include Carl June, Bruce Levine, and Drew Weissman of the Perelman School of Medicine, has launched with $165 million raised to develop a new type of CAR therapy that incorporates mRNA.

Stuart Isaacs of the Perelman School of Medicine evaluates the decline in new cases of monkeypox and speaks on what factors to examine in the virus’s future trajectory.

Stuart Isaacs of the Perelman School of Medicine says that cases of household transmission without sex argue against calling monkeypox an STI, though sex’s frequency as a mode of transmission should still be emphasized.

E. John Wherry of the Perelman School of Medicine says that the Long Covid Research Initiative’s greater risk tolerance and more rapid investment pivoting could enable it to outpace the National Institutes of Health.

Mark Abdelmalek of the Perelman School of Medicine says that health disparities are common across many aspects of medicine and isn’t surprised that monkeypox is following the same trend as COVID-19.